2026 NPPES data Otolaryngology Physician NPI 1639230220 M.D.
Verify on CMS →

SURINDER MALHOTRA, M.D.

Otolaryngology Physician in REGO PARK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
485
Medicare Part D claims · 248 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

SURINDER MALHOTRA, M.D. filed 485 Medicare Part D claims in 2023 as a Otolaryngology Physician in REGO PARK, New York, prescribing 98% generic.

485
Part D claims, 2023
98%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SURINDER MALHOTRA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

485 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

SURINDER MALHOTRA, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SURINDER MALHOTRA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 12/13/2006

NPI 1639230220

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

485 5% vs specialty avg

2023 prescription claims

Specialty avg: 509

Specialty distribution in New York

How Otolaryngology Physician compares to other specialties among New York providers

New York providers

Otolaryngology Physician share within New York

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Otolaryngology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otolaryngology Physician ABMS/AOA estimate

Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SURINDER MALHOTRA, M.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D. credentials at 9229 QUEENS BLVD, REGO PARK, NY, 11374, with a listed phone of (718) 830-9000. NPI 1639230220 was issued on 12/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MALHOTRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 485 prescription claims written by this provider, covering 248 Medicare beneficiaries and totaling roughly $10K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9229 QUEENS BLVD
REGO PARK, NY 11374

Provider Details

NPI 1639230220
Specialty Otolaryngology Physician
Credentials M.D.
Gender Male
NPI Issued 12/13/2006

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to SURINDER MALHOTRA, M.D.. To verify SURINDER MALHOTRA, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SURINDER MALHOTRA, M.D. — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 485 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

485
Total Claims
$10K
Total Drug Cost
248
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
542
Total Day Supply
10,915
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$2K
Generic Drug Cost
$8K
Antibiotic Claims
187

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.17
Gender Split
52% female / 48% male
Age Distribution
<65: 14, 65-74: 145, 75-84: 74, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SURINDER MALHOTRA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Fluticasone Propionate
191
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
146
Neomycin-Polymyxin-Hydrocort
Neomycin/Polymyxin B/Hydrocort
59
Azelastine Hcl
17
Clarithromycin
17
Ciprofloxacin Hcl
16
Neomycin-Polymyxin-Hc
Neomycin/Polymyxin B/Hydrocort
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How SURINDER MALHOTRA, M.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

SURINDER MALHOTRA, M.D.'s 485 claims are below the specialty average of 509.

Nearby Otolaryngology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MALHOTRA.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SURINDER MALHOTRA, M.D.'s specialty?
SURINDER MALHOTRA, M.D. specializes in Otolaryngology Physician and practices in REGO PARK, New York. Credentials: M.D..
How much does SURINDER MALHOTRA, M.D. prescribe under Medicare Part D?
In 2023, SURINDER MALHOTRA, M.D. wrote 485 Medicare Part D claims totaling $10K in drug costs for 248 beneficiaries.
Where is SURINDER MALHOTRA, M.D. located?
SURINDER MALHOTRA, M.D. is located at 9229 QUEENS BLVD, REGO PARK, NY, 11374. Phone: (718) 830-9000.
What is SURINDER MALHOTRA, M.D.'s NPI number?
SURINDER MALHOTRA, M.D.'s National Provider Identifier (NPI) is 1639230220, issued on 12/13/2006.
Does SURINDER MALHOTRA, M.D. prescribe more brand-name or generic drugs?
SURINDER MALHOTRA, M.D.'s prescribing is 2% brand-name and 98% generic drugs by claim count, with $2K in brand drug costs.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does SURINDER MALHOTRA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SURINDER MALHOTRA, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Amoxicillin-Clavulanate Potass, Neomycin-Polymyxin-Hydrocort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SURINDER MALHOTRA, M.D. accept Medicare?
SURINDER MALHOTRA, M.D. appears in CMS Medicare data with 485 Part D claims and 248 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SURINDER MALHOTRA, M.D.'s credentials?
SURINDER MALHOTRA, M.D.'s NPI is 1639230220 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology